Finance

Lists
Why is MDCX up 10,46%?
Dive Deeper
MDCX:NASDAQ
Medicus Pharma Ltd
1,90 $
+10,46%
(+0,18) 1D
13 նոյ, 11:35:25 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDCX...
Open
1,75 $
High
1,97 $
Low
1,70 $
Mkt. cap
3,65 մլն
Avg. vol.
85,80 հզր
Volume
21,68 հզր
52-wk high
127,50 $
52-wk low
1,63 $
EPS
-122,54 $
Shares outstanding
1,92 մլն
No. of employees
16
Open
1,75 $
High
1,97 $
Low
1,70 $
Mkt. cap
3,65 մլն
Avg. vol.
85,80 հզր
Volume
21,68 հզր
52-wk high
127,50 $
52-wk low
1,63 $
EPS
-122,54 $
Shares outstanding
1,92 մլն
No. of employees
16
News stories
From web sources and news partners
About Medicus Pharma Ltd
CEO-
Employees16
Founded2008
HeadquartersConshohocken, Փենսիլվանիա, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitemedicuspharma.com
Analyst ratings
Based on 4 analysts giving stock ratings to MDCX in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MDCX in the last 3 months.
Highest
Current 1,90 $
450,00 $ (+23 585,46%)
Average
171,67 $ (+8 935,74%)
Lowest
15,00 $ (+689,52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kumaraguru Raja
Brookline Capital Markets
Hold
Downgraded
-
-
11/11/2026
Jason McCarthy
Maxim Group
Buy
Maintained
15,00 $
+689,5%
11/09/2026
Matthew Venezia
Alliance Global Partners
Buy
Maintained
50,00 $
+2 531,7%
09/14/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
1,00 $
-47,4%
09/14/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
450,00 $
+23 585,5%
09/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,59 մլն
2,70 մլն
4,91 մլն
1,95 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,20 մլն
5,89 մլն
6,57 մլն
2,51 մլն
Operating expense
7,79 մլն
8,60 մլն
11,48 մլն
4,46 մլն
Total operating expenses
7,79 մլն
8,60 մլն
11,48 մլն
4,46 մլն
Operating income
-7,79 մլն
-8,60 մլն
-11,48 մլն
-4,46 մլն
Other non operating income
-6,88 մլն
-
-
-
EBT including unusual items
-15,07 մլն
-9,04 մլն
-11,68 մլն
-15,17 մլն
EBT excluding unusual items
-14,95 մլն
-8,92 մլն
-11,68 մլն
-5,17 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15,07 մլն
-9,04 մլն
-11,62 մլն
-15,18 մլն
Net profit margin
-
-
-
-
Earnings per share
-22,21
-15,09
-10,50
-11,64
Interest and investment income
-
56,56 հզր
-
-
Interest expense
-272,82 հզր
-374,71 հզր
-205,64 հզր
-712,65 հզր
Net interest expenses
-272,82 հզր
-318,15 հզր
-205,64 հզր
-712,65 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps